Trading / Browse Companies / Tmunity Stock

Tmunity Stock

tmunity.comHealthcareFounded: 2015Funding to Date: $220.28MM

Tmunity is a clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases.

Buy or sell Tmunity stockLearn more about a potential Tmunity IPO
Register for Details

For more details on financing and valuation for Tmunity, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tmunity.

Register Today

Team

Management Team

Graeme Bell
Chief Financial Officer & Executive Vice President
Michael Christiano
Executive Vice President and Chief Business Officer
Bruce Levine Ph.D
Co-Founder & Advisor
Usman Azam MD
President, Chief Executive Officer & Board Member
Christina Coughlin MD
Chief Medical Officer & Executive Vice President
Bruce Blazar MD
Co-Founder & Advisor
Yangbing Zhao Ph.D
Co-Founder & Advisor
Anne Chew Ph.D
Co-Founder, Advisor & Board Member
Jason Krentz
Chief Technology Officer & Head, Technical Operations
James Riley
Co-Founder & Advisor
Carl June MD
Co-Founder & Chief Scientific Advisor

Board Members

Patrick Gray
Anne Chew Ph.D
Usman Azam MD
Garry Nicholson

Other companies like Tmunity in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.6B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Nutrafol
Sector
Healthcare
Last Round Est. Valuation
$150MM
Biosplice Therapeutics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Levels
Sector
Healthcare
Last Round Est. Valuation
$296.3MM
Cerebral
Sector
Healthcare
Last Round Est. Valuation
$4.8B

News

FinSMEs 10/31/2019
Tmunity Secures $75M in Series B Financing | FinSMEs
Tmunity Therapeutics, a Philadelphia, PA-based T-cell immunotherapy company, closed a $75m Series B financing. The round was led by Andreessen Horowitz
Business Wire 01/23/2018
Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer
Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of

Trending Companies

Frequently Asked Questions